Skip to main content
. 2019 Jun 7;10:2529. doi: 10.1038/s41467-019-10404-9

Fig. 6.

Fig. 6

JNK inhibition decreases proliferation of human glioma-derived H3.3K27M cells. a, b Transmitted light pictures (a) and cell viability plots (b) of human glioma-derived cells with wild type (SF9421, black; SF9402, gray) or K27M mutant (SF8628, red) H3.3, treated with different concentrations of JNK inhibitor SP600125. N = 4 for all conditions. Significance was tested for using one-way ANOVA